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peripheral arterial disease
Ruby C. Lo, MD, Rodney P. Bensley, MD, Suzanne E. Dahlberg, PhD, Robina Matyal, MD,
Allen D. Hamdan, MD, Mark Wyers, MD, Elliot L. Chaikof, MD, PhD, and
Marc L. Schermerhorn, MD, Boston, Mass
Objective: Prior studies have suggested treatment and outcome disparities between men and women for lower extremity
peripheral arterial disease after surgical bypass. Given the recent shift toward endovascular therapy, which has increasingly
been used to treat claudication, we sought to analyze sex disparities in presentation, revascularization, amputation, and
inpatient mortality.
Methods: We identiﬁed individuals with intermittent claudication and critical limb ischemia (CLI) using International
Classiﬁcation of Diseases, Ninth Revision codes in the Nationwide Inpatient Sample from 1998 to 2009. We compared
presentation at time of intervention (intermittent claudication vs CLI), procedure (open surgery vs percutaneous
transluminal angioplasty or stenting vs major amputation), and in-hospital mortality for men and women. Regional and
ambulatory trends were evaluated by performing a separate analysis of the State Inpatient and Ambulatory Surgery
Databases from four geographically diverse states: California, Florida, Maryland, and New Jersey.
Results: From the Nationwide Inpatient Sample, we identiﬁed 1,797,885 patients (56% male) with intermittent claudi-
cation (26%) and CLI (74%), who underwent 1,865,999 procedures (41% open surgery, 20% percutaneous transluminal
angioplasty or stenting, and 24% amputation). Women were older at the time of intervention by 3.5 years on average and
more likely to present with CLI (75.9% vs 72.3%; odds ratio [OR], 1.21; 95% conﬁdence interval [CI], 1.21-1.23; P <
.01). Women were more likely to undergo endovascular procedures for both intermittent claudication (47% vs 41%; OR,
1.27; 95% CI, 1.25-1.28; P < .01) and CLI (21% vs 19%; OR, 1.14; 95% CI, 1.13-1.15; P < .01). From 1998 to 2009,
major amputations declined from 18 to 11 per 100,000 in men and 16 to 7 per 100,000 in women, predating an increase
in total CLI revascularization procedures that was seen starting in 2005 for both men and women. In-hospital mortality
was higher in women regardless of disease severity or procedure performed even after adjusting for age and baseline
comorbidities (.5% vs .2% after percutaneous transluminal angioplasty or stenting for intermittent claudication; 1.0% vs
.7% after open surgery for intermittent claudication; 2.3% vs 1.6% after percutaneous transluminal angioplasty or stenting
for CLI; 2.7% vs 2.2% after open surgery for CLI; P < .01 for all comparisons).
Conclusions: There appears to be a preference to perform endovascular over surgical revascularization among women, who
are older and have more advanced disease at presentation. Percutaneous transluminal angioplasty or stenting continues to
be popular and is increasingly being performed in the outpatient setting. Amputation and in-hospital mortality rates have
been declining, and women now have lower amputation but higher mortality rates than men. Recent improvements in
outcomes are likely the result of a combination of improved medical management and risk factor reduction. (J Vasc Surg
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://dx.doi.org/10.1016/j.jvs.2013.07.114Individuals age >65 years now constitute the fastest
growing segment of the U.S. population.1 As the popula-
tion has matured, the number of individuals with peripheral
arterial disease (PAD) has proportionately increased. Esti-
mates from the Centers for Disease Control indicate
PAD affects approximately 8 million Americans.2 Women
continue to outnumber men in the older age groups. In
2010, women $65 years of age outnumbered their male
counterparts by 32%, and there were more than twice as
many women age $85 years as men.1
Sex-related differences have been demonstrated in
other vascular diseases. For instance, women may derive
less beneﬁt from carotid endarterectomy for symptomatic
moderate carotid stenosis than men3 and have a higher
risk of postoperative strokes, transient ischemic attacks,
and death after carotid endarterectomy for asymptomatic
disease.4 Women with abdominal aortic aneurysms (AAAs)
have a higher rate of rupture at any given diameter.5409
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more common after endovascular AAA repair,6-8 and peri-
operative mortality is higher among women following open
AAA repair.9 Multiple hypotheses have been proposed to
explain these differences, including fewer screening and
preventative measures in women, the inﬂuence of sex
hormones, and differences in body size and anatomy.
Studies evaluating sex differences after lower extremity
bypass have been equivocal. Earlier reports suggested
worse long-term patency, perioperative mortality, and
long-term survival in women.10,11 More recent studies,
including several systematic reviews, found no major differ-
ences in patency rates, amputation-free, and overall
survival.12-14 The emergence of endovascular therapy as
a safe and effective adjunct to the gold standard of surgical
bypass15,16 has transformed the treatment of lower
extremity PAD and angioplasty, and stenting has sup-
planted peripheral bypass as the most commonly per-
formed treatment.17,18 We therefore sought to assess sex-
related differences in treatment and outcomes of lower
extremity PAD associated with this shift in treatment
paradigm.METHODS
This study examined revascularization and amputation
procedures among patients with PAD using three databases
from the Healthcare Cost and Utilization Project
(HCUP): the Nationwide Inpatient Sample (NIS), the
State Inpatient Databases (SIDs), and the State Ambula-
tory Surgery Databases (SASDs). The NIS is the largest
all-payer inpatient care database in the United States.
Capturing roughly 8 million discharges per year, it approx-
imates a 20% sample of all U.S. hospital stays. Discharge
weights are used to generate national estimates. Using
data from 1998 to 2009, we performed a search using
International Classiﬁcation of Diseases, Ninth Revision
(ICD-9) diagnosis codes to identify patients with any
primary diagnosis code (reason for admission) or secondary
diagnosis code indicating arterial occlusive disease (PAD)
of the extremities (Supplementary Table, online only), cat-
egorizing them by presentation: intermittent claudication
vs critical limb ischemia (CLI). CLI was deﬁned by any
primary or secondary diagnosis code for rest pain, ulcer, oste-
omyelitis, or gangrene. Patients without a primary or
secondary code for PAD and those whose disease severity
could not be identiﬁed (ie, no codes for either claudication
or CLI) were excluded. Using ICD-9 procedure codes, we
then identiﬁed patients who underwent open revasculariza-
tion (endarterectomy, aortoiliacfemoral bypass, or infraingui-
nal bypass), endovascular revascularization (angioplasty,
stenting, atherectomy, or mechanical thrombectomy) or
major amputation (below or above knee). Admissions
involving both endovascular and open procedures during
the same hospital admission are labeled “openþendo.”These
admissions represent either hybrid procedures, open surgery
after failed endovascular intervention, or procedures per-
formed on different limbs.HCUP does not offer a national ambulatory surgery
database. We therefore utilized the SASD, which contains
information from hospital-afﬁliated and freestanding
ambulatory surgery sites, to evaluate trends in outpatient
procedures. The SASD captures all surgeries that are per-
formed on the same day in which patients are admitted
and released. Therefore, patients admitted under “observa-
tion” status who stay overnight would be captured in the
NIS rather than the SASD. Additionally, we veriﬁed our
ﬁndings from the NIS using the SID. The NIS is a 20%
weighted sample drawn from individual SIDs. However,
because not all states contribute data to the NIS and
because different states began contributing at different
times, it is advisable to verify results from the NIS against
other sources. Both the SID and SASD contain 100% of
discharge abstracts from each participating state, and
thus, the SID serves as a useful comparator for the NIS.
Forty-six states participate in the SID, and 32 in the
SASD. We used the 2005 to 2009 SID and SASD from
four geographically diverse states: California, Florida,
Maryland, and New Jersey. Each state was initially analyzed
separately. Because we found that the overall procedural
trends were consistent from state to state, we aggregated
the states into one composite dataset for simplicity. As
with the NIS data, diagnoses and procedures were identi-
ﬁed using ICD-9 codes. However, the California and
Maryland SASDs report procedures using current proce-
dural terminology (CPT) codes rather than ICD-9 codes.
Thus, to classify the procedures performed, we chose
CPT codes that most closely corresponded to the ICD-9
codes used to classify procedures within the other databases
(Supplementary Table, online only).
Statistical analyses were performed using SAS (v. 9.3;
SAS Institute, Cary, NC) and SAS Callable SUDAAN v.
10 (Research Triangle Institute, Research Triangle Park,
NC). Data were indexed to the population using
national-, state-, and sex-speciﬁc population data from the
U.S. Census Bureau. Comparisons of categorical covariates
(demographics, procedures, and outcomes) between men
and women were performed using the c2 test. Continuous
variables were compared using the Student t-test and Wil-
coxon rank-sum test. The Cochrane-Armitage trend test
was used to detect signiﬁcant changes in categorical
outcomes over time. A multivariable logistic regression
model, which included age, sex, race, disease severity, and
baseline comorbidities, was used to determine predictors
of in-hospital mortality. Covariates included in the model
have been previously shown to inﬂuence in-hospital survival
in patients with PAD and therefore were likely sufﬁcient to
control for most confounding. Statistical signiﬁcance was
deﬁned as P < .005 using the Bonferroni adjustment.
RESULTS
NIS (inpatient procedures)
Using the discharge weights supplied by HCUP, we
identiﬁed an estimated 12,248,188 admissions for extremity
atherosclerosis (Fig 1). From this group, we identiﬁed
Fig 1. Flowchart diagramming identiﬁcation of the study cohort.
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tion (26.2%) or CLI (73.8%) with 1,865,999 procedures.
Demographics and comorbidities
Overall, women were older than men for both inter-
mittent claudication and CLI (Table I). Between 1998
and 2009, the age of individuals with intermittent claudica-
tion increased (men: 65.6 to 65.8 years; women: 67.8 to
68.5 years), whereas that for CLI decreased (men: 69.4
to 68.1 years; women: 73.0 to 71.4 years). The age of
patients undergoing amputation fell by 2.4 years for men
and 3.0 years for women. Compared with patients with
intermittent claudication, those with CLI were older, less
likely to be white, and had a higher prevalence of diabetes
mellitus, congestive heart failure, and chronic renal failure
(Table I). Men were more likely to be white, have concur-
rent diagnoses of diabetes mellitus, coronary artery disease,
chronic obstructive pulmonary disease, and chronic renal
failure. In contrast, women had higher rates of hyperten-
sion, congestive heart failure, and cerebrovascular disease.
Presentation
Among all patients with PAD, severity of disease was
classiﬁed as intermittent claudication in 26% of patients
and CLI in 74%. When considering only those undergoing
revascularization, 35% were classiﬁed as intermittent claudi-
cation and 65% as CLI. For all years of the study except
2009, women were more likely than men to present with
CLI than intermittent claudication with an overall 1.2
higher odds (95% conﬁdence interval [CI], 1.21-1.23;
P < .01). Among only patients undergoing revasculariza-
tion, women were again more likely to present with CLI
(odds ratio [OR], 1.19; 95% CI, 1.18-1.20; P < .001).
After adjusting for age and baseline comorbidities, women
were still more likely to present with CLI (OR, 1.15; 95%
CI, 1.13-1.16; P < .001).Treatment modality
Intermittent claudicationeinpatient (NIS). The
number of endovascular procedures rose over the 12-year
study period (Fig 2). Between 1998 and 2009, endovas-
cular procedures increased by 126% for men and 167% for
women. A peak in endovascular procedures was seen in
2007 when numbers reached 13 per 100,000 in men and
nine per 100,000 in women. Concurrently, open proce-
dures fell by 26% for men and 26% for women. The total
number of revascularization procedures remained stable
(around 16-17 per 100,000 in men and 10-11 per 100,000
in women) until 2005 when numbers began climbing. This
increase in revascularization procedures was attributable to
the sharp rise in endovascular procedures since the number
of open procedures continued to fall until 2005 whereafter
they remained stable, and the number of openþendo
procedures remained stable throughout. Total inpatient
revascularizations peaked in 2006 at 23 per 100,000 in
men and 14 per 100,000 in women, subsequently
declining to eight per 100,000 in men and seven per
100,000 in women.
As a proportion of all inpatient procedures performed,
endovascular revascularizations increased steadily (from
22% in men and 24% in women in 1998), peaking in
2007 (at 56% in men and 63% in women), and declining
thereafter (to 45% in men and 53% in women by 2009).
This was mirrored by a decline and subsequent rebound
in the proportion of inpatient open procedures. The
proportion of openþendo procedures remained stable
around 7% for both men and women. Women with inter-
mittent claudication were more likely to undergo an endo-
vascular procedure (OR, 1.27; 95% CI, 1.25-1.28; P <
.001) compared with men. This remained the case after
adjustment for demographics and comorbidities (OR,
1.20; 95% CI, 1.19-1.23; P < .001).
Intermittent claudicationeinpatient and outpatient
(SID and SASD). The number of open revascularization
procedures remained relatively stable for both men and
women across the 5-year period at approximately seven per
100,000 for men and four per 100,000 for women (Fig 3,
a). Rather than seeing a decline in endovascular procedural
volume after 2007 as was observed with the NIS (inpatient)
data, the volume of endovascular procedures documented
in the state data continued to increase. Because the state
data includes procedures performed in the ambulatory
setting, this discrepancy represents a shift toward performing
endovascular procedures in the outpatient setting.
Inpatient endovascular procedures increased from 6.0
to 7.1 per 100,000 in men and 4.5 to 7.1 per 100,000
in women, representing a 17% increase in men and 19%
increase in women. The growth in volume of endovascular
procedures was even more evident in the ambulatory
setting, increasing from 7.0 to 13.2 per 100,000 for men
and 4.5 to 8.4 per 100,000 in women. This represented
an 88% increase in men and 87% increase in women. As
a proportion of all endovascular procedures, those being
performed in the outpatient setting increased from 54%
Table I. Demographics and comorbidities of patients undergoing revascularization or amputation by presentation
(intermittent claudication vs critical limb ischemia [CLI])
Intermittent claudication CLI
Men
(n ¼ 281,852), %
Women
(n ¼ 189,273), % P value
Men
(n ¼ 734,059), %
Women
(n ¼ 593,731), % P value
Mean age, years 65.9 68.3 <.001 68.7 72.4 <.001
Race
White 84.3 82.6 71.1 65.5
Black 7.7 10.1 <.001 16.6 22.9 <.001
Other 8.0 7.3 12.3 11.6
DM 30.7 29.3 <.001 54.7 51.7 <.001
CAD 50.9 41.6 <.001 41.2 34.6 <.001
HTN 61.6 66.5 <.001 44.4 53.2 <.001
CHF 6.9 7.8 <.001 19.5 21.3 <.001
COPD 21.0 20.3 <.001 20.9 16.9 <.001
CVD 6.3 7.3 <.001 4.4 4.8 <.001
CRF 4.6 4.1 <.001 14.4 12.7 <.001
CAD, Coronary artery disease; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; CRF, chronic renal failure; CVD, cerebral
vascular disease; DM, diabetes mellitus; HTN, hypertension.
Fig 2. Open and endovascular procedures performed for intermittent claudication. Women were more likely than men
to undergo an endovascular procedure.
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61% in 2009 for women. As seen in the NIS, women were
more likely to undergo endovascular procedures (univar-
iate: OR, 1.22; 95% CI, 1.18-1.26; P < .001; multivari-
able: OR, 1.32; 95% CI, 1.30-1.46; P ¼ .002) and less
likely to undergo open surgery.
CLIeinpatient (NIS). The trend in procedural
volumes for patients with CLI was similar to that observed
for patients with intermittent claudication (Fig 4, a).
Endovascular procedures increased 206% (from four to 14
per 100,000) in men and 191% (from four to 11 per
100,000) in women. Open procedures fell 37% in men
(from 21 to 14 per 100,000) and 46% in women (from 16
to 9 per 100,000). The rate of expansion of endovascular
procedures approximated the rate of decline in open
procedures such that the number of total revascularizations
performed for CLI remained relatively stable until 2006.
From 2006 to 2008, the rise in endovascular procedurescontinued while open procedures stabilized, producing an
overall increase in total revascularization procedures.
Amputations performed for CLI also declined in both men
and women (Fig 4, b): by 40% (from 18 to 11 per 100,000)
in men and by 57% in women (from 16 to seven per
100,000). Notably, amputation numbers were decreasing
prior to the rise of total revascularization procedures
in 2006.
The volume of openþendo procedures increased
slightly in men and remained stable for women (Fig 4,
a). Hospitalizations that involved both revascularization
and amputation remained stable around one to two per
100,000 for both men and women.
Compared with other vascular procedures performed
for CLI, the proportion of inpatient endovascular revascu-
larizations increased dramatically from 9% in men and 10%
in women in 1998, reaching a plateau in 2007 around 32%
in men and 37% in women. The proportion of open
Fig 3. Volume of revascularization procedures in California, Florida, Maryland, and New Jersey during admissions for
(a) intermittent claudication and (b) critical limb ischemia (CLI). Women were more likely to undergo endovascular
procedures and less likely to undergo open surgery.
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and 42% in women in 1998, also plateauing from 2007
to 2008 at 31% for men and 28% for women. Amputations
were performed less often relative to revascularization
procedures, declining from 38% to 25% in men and from
41% to 23% in women. Women with CLI were more likely
to undergo endovascular procedures (univariate: OR, 1.14;
95% CI, 1.13-1.15; P < .001; multivariable: OR, 1.11;
95% CI, 1.09-1.12; P ¼ .004) and less likely to undergo
an open procedure. Overall, women were more likely
than men to undergo major amputation (univariate: OR,
1.04; 95% CI, 1.03-1.05; P < .001; multivariable: OR,
1.07; 95% CI, 1.01-1.12; P < .001) but were consistently
less likely to after 2005.CLIeinpatient and outpatient (SID and SASD).
Open procedural volume remained stable (14 per 100,000
for men and nine per 100,000 for women) (Fig 3, b).
Inpatient endovascular procedural volume increased 103%
for men and 83% for women. Outpatient endovascular
procedural volume made even greater gains, increasing
114% for men and 132% for women. However, there were
still 2.7 times more inpatient than outpatient endovascular
procedures for both men and women. Again, the decline in
the volume of endovascular procedures after 2007 that was
observed in the inpatient (NIS) data was not observed for
the state data, indicating procedures have shifted to the
outpatient setting. This trend was observed to be greater
for CLI than intermittent claudication (Fig 3, b).
Fig 4. a, Revascularization and (b) amputation procedures performed for critical limb ischemia (CLI). Women were
more likely than men to undergo endovascular intervention whereas men were more likely to undergo open revas-
cularization. Amputations were more frequent in women except after 2005.
Fig 5. Volume of major amputations performed in California,
Florida, Maryland, and New Jersey. Women were less likely to
undergo amputation but the number of amputations declined for
both men and women.
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men and women (Fig 5).Women with CLI were more likely
to have an endovascular intervention compared with men(univariate: OR, 1.20; 95% CI, 1.17-1.23; P < .001;
multivariable: OR, 1.24; 95% CI, 1.20-1.30; P ¼ .001) and
were less likely to undergo major amputation (univariate:
OR, .89, 95% CI, .87-.92; P < .001; multivariable: OR,
0.97, 95% CI, 0.93-0.98; P < .001).
In-hospital mortalityeinpatient (NIS)
Between 1998 and 2009, the number of in-hospital
deaths among patients with intermittent claudication
remained low (less than .10 per 100,000) (Fig 6, a) and
declined signiﬁcantly for both men and women regardless
of procedure (P < .01 for open, endovascular, and open-
þendo procedures). Mortality was lowest among patients
undergoing endovascular procedures and highest among
those undergoing openþendo procedures. However,
women had higher mortality rates than men for all proce-
dures (open: 1.0% vs .7%; OR, 1.37; 95% CI, 1.25-1.49;
P < .01; endovascular: .5% vs .2%; OR, 1.99; 95% CI,
1.72-2.30; P < .01; openþendo: 1.8% vs .8%, OR, 2.13;
95% CI, 1.76-2.58; P < .01).
For patients with CLI, the number of in-hospital
deaths declined for all patients except for those undergoing
endovascular procedures, who experienced an increase of
86% (from .10 to .19 per 100,000 for men and 88%
from .11 to .21 per 100,000 for women) (Fig 6, b).
Fig 6. Annual in-hospital mortality by procedure and gender among (a) patients with intermittent claudication, (b)
patients with critical limb ischemia (CLI) undergoing revascularization, and (c) patients with CLI undergoing
amputation. Over the study period, in-hospitality mortality declined for both men and women, but was persistently
higher in women.
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undergoing open and endovascular intervention. Both
absolute number of deaths and mortality rate of men and
women undergoing amputation declined (Fig 6, c). In-
hospital mortality rates declined signiﬁcantly (P < .01)
for both men and women for all procedures evaluated.
However, women again experienced higher mortality than
men regardless of procedure (open: 2.7% vs 2.2%; OR,1.23; 95% CI, 1.19-1.28; P < .01; endovascular: 2.3% vs
1.6%; OR, 1.41; 95% CI, 1.33-1.49; P < .01; openþendo:
4.0% vs 3.2%; OR, 1.28; 95% CI, 1.18-1.38; P< .01; major
amputation: 6.6% vs 6.2%; OR, 1.06; 95% CI, 1.04-1.09;
P < .01; revascularization with amputation: 9.7% vs 8.7%;
OR, 1.13; 95% CI, 1.06-1.20; P # .01).
Multivariable logistic regression revealed female sex to
be a signiﬁcant predictor of in-hospital mortality after
Table II. Multivariable predictors of in-hospital mortality by procedure
Open Endovascular Major amputation
OR 95% CI P OR 95% CI P OR 95% CI P
Female 1.2 1.2-1.3 <.001 1.4 1.3-1.5 <.001 1.1 1.0-1.1 <.001
CLI 2.5 2.4-2.6 <.001 4.8 4.4-5.3 <.001 1.0 0.8-1.2 0.650
Age category, years
<40 - - - - - - - - -
40-49 2.0 1.3-3.0 .001 0.6 0.4-0.9 .027 1.5 1.3-1.9 <.001
50-59 3.0 2.0-4.5 <.001 0.9 0.6-1.3 .607 1.8 1.5-2.2 <.001
60-69 4.7 3.2-7.0 <.001 1.4 0.9-2.0 .113 2.4 2.0-2.8 <.001
70-79 6.6 4.5-9.8 <.001 1.8 1.2-2.7 .003 2.9 2.4-3.4 <.001
$80 8.5 5.7-12.6 <.001 2.3 1.5-3.4 <.001 2.7 2.3-3.3 <.001
CHF 2.7 2.6-2.8 <.001 2.6 2.5-2.8 <.001 1.9 1.9-2.0 <.001
CRF 1.5 1.5-1.6 <.001 1.1 1.1-1.2 .001 1.3 1.3-1.4 <.001
CVD 1.7 1.6-1.8 <.001 1.7 1.6-1.9 <.001 1.8 1.7-1.9 <.001
COPD 1.2 1.1-1.2 <.001 1.4 1.3-1.5 <.001 1.2 1.1-1.2 <.001
DM 0.6 0.6-0.7 <.001 0.7 0.6-0.7 <.001 0.7 0.6-0.7 <.001
CAD 0.7 0.65-0.69 <.001 0.7 0.6-0.7 <.001 0.69 0.68-0.71 <.001
HTN 0.3 0.31-0.34 <.001 0.3 0.3-0.4 <.001 0.36 0.35-0.37 <.001
White race 1.00 0.97-1.03 .846 1.1 1.0-1.1 .109 1.11 1.09-1.14 <.001
CAD, Coronary artery disease; CHF, congestive heart failure; CI, conﬁdence interval; CLI, critical limb ischemia; COPD, chronic obstructive pulmonary
disease; CRF, chronic renal failure; CVD, cerebral vascular disease; DM, diabetes mellitus; HTN, hypertension; OR, odds ratio.
JOURNAL OF VASCULAR SURGERY
416 Lo et al February 2014adjustment for age, disease severity, race, and other base-
line demographics and comorbidities (Table II). The nega-
tive impact of female sex was greatest for endovascular
procedures and least for major amputation. Another inter-
esting ﬁnding was that age had a substantially more nega-
tive impact on in-hospital mortality among patients
undergoing bypass compared with those undergoing endo-
vascular procedures or amputation whereas disease severity
(CLI vs intermittent claudication) had a more negative
impact on in-hospital mortality among patients undergoing
endovascular procedures.
DISCUSSION
The goal of our study was to elucidate differences in
presentation, treatment, and outcomes between men and
women undergoing revascularization for lower extremity
PAD. We found that women undergoing procedural hospi-
talizations presented at an older age, with more advanced
disease, were preferentially treated with endovascular
procedures, and experienced higher mortality for both
intermittent claudication and CLI.
Reviewing inpatient discharge data from 3 state
agencies from 1998 to 2007, Egorova et al similarly found
that women were less likely to undergo surgical bypass.19
However, they found no differential utilization of endovas-
cular procedures between sexes, possibly because they
analyzed all hospitalizations (including those in which no
procedure was performed), whereas we only considered
procedural hospitalizations. There are several possible
reasons women are less likely to undergo open revascular-
izations. The Bypass vs Angioplasty in Severe Ischaemia
of the Leg (BASIL) study compared angioplasty and stent-
ing to open bypass for infrainguinal CLI20 and suggested
patients should be offered open bypass as ﬁrst line therapy
as long as they have suitable vein conduit, are ﬁt enough toundergo surgery, and have a life expectancy greater than
2 years.21 Given that women with lower extremity PAD
are generally older and present with more advanced
disease, fewer may be good candidates for surgical bypass
than men. Additionally, it is possible women are less likely
to have adequate venous conduit due to smaller vessel size
and in fact, vein grafts are reportedly used less frequently in
women than in men.22
Though the trend was more dramatic in women,
amputations declined substantially for both sexes
throughout the study period. Of note, this decline was
well under way prior to the steep rise in endovascular
(and consequently total revascularization) procedures in
the latter one-half of the 2000s. Indeed, between 1998
and 2003, the number of amputations performed per
year had already fallen 17% in men and 30% in women.
This observation challenges proposed theories that declines
in amputations have been related to increased utilization of
and/or advances in endovascular technology23 or the
increase in total numbers of all revascularization proce-
dures.24,25 Rather, it suggests that other factors, perhaps
more aggressive control of cardiovascular risk factors
(smoking cessation, cholesterol-lowering medications, anti-
platelet therapy, aggressive diabetes management) and
improved wound care may have had a greater impact on
limb salvage than procedural interventions.
Over the study period, in-hospitality mortality declined
for both men and women, but was persistently higher in
women. Female sex remained a signiﬁcant independent
predictor of mortality regardless of procedure. Voyouka
et al also found that women had higher procedural
mortality than men for open and endovascular revasculari-
zation and major amputation, even after adjusting for age
and other demographic factors and comorbidities.26 In
fact, they found that advanced age (>70 years) actually
JOURNAL OF VASCULAR SURGERY
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suggesting we cannot attribute the discrepancy in mortality
rates entirely to the age gap between men and women.
One possibility is the relative underutilization of preventa-
tive care in women. For example, antiplatelet, lipid-
lowering, and beta-blocker medications are underutilized
to a greater degree in women compared with men among
patients with cardiovascular disease and PAD.27-29 Even
when treated, women are less likely to achieve goal blood
pressure, target low-density lipoprotein, and hemoglobin
A1c levels.30,31Inferior optimization of medical manage-
ment may put women at higher risk for postoperative
cardiovascular events and death.
Using state ambulatory data, we found that endovascu-
lar (and thus total revascularization procedural) volume is
not declining but rather being shifted into the outpatient
setting, at least in these four states. Egorova et al found
a similar increase in ambulatory endovascular therapy using
1998-2007 New York state data.19 Although outpatient
endovascular interventions for CLI are growing at a faster
rate than those for intermittent claudication, the latter still
make up the majority of those undergoing same-day
surgery. Patients with CLI are more likely to experience
complications and require admission for wound care and
parenteral antibiotics. Multiple studies have championed
the safety and cost-effectiveness of outpatient endovascular
revascularization but most have looked only at patients
with claudication,32-34 and there is currently limited
evidence for patients with CLI.35
Our study has several limitations resulting from the use
of administrative databases. In addition to coding error,
because HCUP databases lack information indicating later-
ality, it was impossible to know if patients who had proce-
dure codes for both percutaneous transluminal
angioplasty or stenting and open surgical bypass (approxi-
mately 6%-7% of patients), as well as patients who under-
went both revascularization (either percutaneous
transluminal angioplasty or stenting or open) and amputa-
tion (approximately 3% of patients) had those procedures
performed on the same leg. Because the NIS is an adminis-
trative database with limited clinical information, aside from
in-hospital mortality, outcomes of revascularization (eg,
patency, wound healing, etc), including postdischarge
events, cannot be assessed. Additionally, there is no way
to track patients in the NIS after discharge, and therefore,
long-term outcomes cannot be studied. For this reason, it
is also unknown how many admissions actually represent
readmission and reintervention. Furthermore, whereas the
majority of the HCUP databases used ICD-9 procedure
codes, the California and Maryland SASD used CPT codes.
Using two separate classiﬁcation systems may make state vs
nationwide and inpatient vs outpatient comparisons more
difﬁcult to interpret. However, while CPT codes are more
speciﬁc (they indicate site/anatomic level), the categories
of procedures we chose (eg, endovascular vs open revascu-
larization and major amputation) are broad enough such
that they should be captured at similar rates regardless of
classiﬁcation system used. Indeed, results observed in theCalifornia and Maryland SASDs correlated well with those
from the New Jersey and Florida SASDs. Finally, although
trends were similar between the state databases when
analyzed individually, results derived from the SIDs and
SASDs of the four states we chose may be less generalizable
since they include only four states.
CONCLUSIONS
Women undergoing vascular procedures for lower
extremity PAD are older and have more advanced disease
than men. Perhaps for these reasons, there appears to be
a preference to perform endovascular procedures in women
and open procedures in men. Endovascular procedures
continue to increase, and many of these are now being per-
formed in the outpatient setting. Amputation rates have
declined steadily, and women now have lower rates than
men. In-hospital mortality for both men and women also
continues to decline. These improvements do not neces-
sarily correlate with the increased utilization of endovascu-
lar (or total number of) procedures and likely resulted from
both continued improvements in medical management
and risk factor reduction as well as advances in surgical
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Supplementary Table (online only). International Classiﬁcation of Diseases, Ninth Revision (ICD-9) and current
procedural terminology (CPT) diagnosis and procedure codes
ICD-9 diagnosis code Description
Atherosclerosis of the extremities
440.20 Atherosclerosis of the extremities, unspeciﬁed
440.21 Atherosclerosis of the extremities with intermittent claudication
440.22 Atherosclerosis of the extremities with rest pain
440.23 Atherosclerosis of the extremities with ulceration
440.24 Atherosclerosis of the extremities with gangrene
440.29 Atherosclerosis, other
440.30 Atherosclerosis of unspeciﬁed graft of the extremities
440.31 Atherosclerosis of autologous vein bypass graft of the extremities
440.32 Atherosclerosis of nonautologous vein bypass graft of the extremities
443.9 Peripheral vascular disease, unspeciﬁed (intermittent claudication NOS, peripheral
angiopathy NOS, peripheral vascular disease NOS)
Intermittent claudication
440.21 Atherosclerosis of the extremities with intermittent claudication
CLI
730.05 Acute osteomyelitis of pelvic region and thigh
730.06 Acute osteomyelitis of lower leg
730.07 Acute osteomyelitis of ankle and foot
730.09 Acute osteomyelitis of multiple sites
444.22 Arterial embolism and thrombosis of lower extremity
444.81 Arterial embolism and thrombosis of iliac artery
440.22 Atherosclerosis of the extremities with rest pain
440.23 Atherosclerosis of the extremities with ulceration
440.24 Atherosclerosis of the extremities with gangrene
682.6 Cellulitis of leg, except foot
682.7 Cellulitis of foot, except toes
681.1 Cellulitis of toe
730.15 Chronic osteomyelitis of pelvic region and thigh
730.16 Chronic osteomyelitis of lower leg
730.17 Chronic osteomyelitis of ankle and foot
730.19 Chronic osteomyelitis of multiple sites
707.10 Chronic ulcer of lower limb, unspeciﬁed
707.11 Chronic ulcer of thigh
707.12 Chronic ulcer of calf
707.13 Chronic ulcer of ankle
707.14 Chronic ulcer of heel and midfoot
707.15 Chronic ulcer of other part of foot (toes)
707.19 Chronic ulcer of other part of lower limb
785.4 Gangrene
040.0 Gas gangrene
730.25 Unspeciﬁed osteomyelitis of pelvic region and thigh
730.26 Unspeciﬁed osteomyelitis of lower leg
730.27 Unspeciﬁed osteomyelitis of ankle and foot
730.29 Unspeciﬁed osteomyelitis of multiple sites
Endovascular revascularization
39.50 Angioplasty or atherectomy of other noncoronary vessel(s)
39.90 Insertion of noncoronary stent(s) or stent graft(s)
Open revascularization
39.25 Aorta-iliac-femoral bypass
38.18 Endarterectomy of lower limb artery
39.29 Other (peripheral) vascular shunt or bypass
Major amputation
84.15 Amputation below knee
84.17 Amputation above knee
(Continued on next page)
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CPT procedure code Description
Endovascular revascularization
35470 Transluminal balloon angioplasty, percutaneous; tibioperoneal trunk or branches, each vessel
35473 Transluminal balloon angioplasty, percutaneous; iliac
35474 Transluminal balloon angioplasty, percutaneous; femoral-popliteal
75962 Transluminal balloon angioplasty; peripheral artery, radiological supervision and interpretation
75964 Transluminal balloon angioplasty, each additional peripheral artery, radiological supervision and interpretation
35492 Transluminal peripheral atherectomy, percutaneous; iliac
35493 Transluminal peripheral atherectomy, percutaneous; femoral-popliteal
35495 Transluminal peripheral atherectomy, percutaneous; tibioperoneal trunk and branches
75992 Transluminal atherectomy, peripheral artery, radiological supervision and interpretation
75993 Transluminal atherectomy, each additional peripheral artery, radiological supervision and interpretation
37184 Primary percutaneous transluminal mechanical thrombectomy, noncoronary, arterial or arterial bypass graft, including
ﬂuoroscopic guidance and intraprocedural pharmacological thrombolytic injection(s); initial vessel
37185 Primary percutaneous transluminal mechanical thrombectomy, noncoronary, arterial or arterial bypass graft, including
ﬂuoroscopic guidance and intraprocedural pharmacological thrombolytic injection(s); second and all subsequent
vessel(s) within the same vascular family
37186 Secondary percutaneous transluminal thrombectomy (eg, nonprimary mechanical, snare basket, suction technique),
noncoronary, arterial or bypass graft, including ﬂuoroscopic guidance and intraprocedural pharmacological
thrombolytic injections, provided in conjunction with percutaneous intervention other than primary mechanical
thrombectomy
37187 Percutaneous transluminal mechanical thrombectomy, vein(s), including intraprocedural pharmacological
thrombolytic injections and ﬂuoroscopic guidance
37188 Percutaneous transluminal mechanical thrombectomy, vein(s), including intraprocedural pharmacological
thrombolytic injections and ﬂuoroscopic guidance, repeat treatment on subsequent day during course of
thrombolytic therapy
37205 Transcatheter placement of an intravascular stent(s) (except coronary, carotid, and vertebral), percutaneous; initial
vessel
37206 Transcatheter placement of an intravascular stent(s), each additional vessel (except coronary, carotid, and vertebral),
percutaneous; initial vessel
75960 Transcatheter introduction of intravascular stent(s) (except coronary, carotid, and vertebral vessel), percutaneous
and/or open, radiological supervision and interpretation, each vessel
Open revascularization
35500 Harvest of upper extremity vein, one segment, for lower extremity bypass procedure
35521 Bypass graft, with vein; axillary-femoral
35533 Bypass graft, with vein; axillary-femoral-femoral
35541 Bypass graft, with vein; aortoiliac or bi-iliac
35546 Bypass graft, with vein; aortofemoral or bifemoral
35548 Bypass graft, with vein; aortoiliofemoral, unilateral
35549 Bypass graft, with vein; aortoiliofemoral, bilateral
35551 Bypass graft, with vein; aortofemoral-popliteal
35556 Bypass graft, with vein; femoral-popliteal
35558 Bypass graft, with vein; femoral-femoral
35563 Bypass graft, with vein; ilioiliac
35565 Bypass graft, with vein; iliofemoral
35566 Bypass graft, with vein; femoral-anterior tibial, posterior tibial, peroneal artery or other distal vessels
35571 Bypass graft, with vein; popliteal-tibial, -peroneal artery or other distal vessels
35583 In-situ vein bypass; femoral-popliteal
35585 In-situ vein bypass; femoral-anterior tibial, posterior tibial, or peroneal artery
35587 In-situ vein bypass; popliteal-tibial, peroneal
35621 Bypass graft, with other than vein; axillary-femoral
35623 Bypass graft, with other than vein; axillary-popliteal or etibial
35641 Bypass graft, with other than vein; aortoiliac or bi-iliac
35646 Bypass graft, with other than vein; aortobifemoral
35647 Bypass graft, with other than vein; aortofemoral
35651 Bypass graft, with other than vein; aortofemoral-popliteal
35654 Bypass graft, with other than vein; axillary-femoral-femoral
35656 Bypass graft, with other than vein; femoral-popliteal
35661 Bypass graft, with other than vein; femoral-femoral
35663 Bypass graft, with other than vein; ilioiliac
35665 Bypass graft, with other than vein; iliofemoral
35666 Bypass graft, with other than vein; femoral-anterior tibial, posterior tibial, or peroneal artery
35671 Bypass graft, with other than vein; popliteal-tibial or eperoneal artery
35681 Bypass graft, composite, prosthetic and vein
35682 Bypass graft, autogenous composite, two segments of veins from two locations
35683 Bypass graft, autogenous composite, three or more segments of vein from two or more locations
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35685 Placement of vein patch or cuff at distal anastomosis of bypass graft, synthetic conduit
35686 Creation of distal arteriovenous ﬁstula during lower extremity bypass surgery (nonhemodialysis)
35700 Reoperation, femoral-popliteal or femoral (popliteal)-anterior tibial, posterior tibial, peroneal artery or other distal
vessel
35351 Thromboendarterectomy, with or without patch graft; iliac
35355 Thromboendarterectomy, with or without patch graft; iliofemoral
35361 Thromboendarterectomy, with or without patch graft; combined aortoiliac
35363 Thromboendarterectomy, with or without patch graft; combined aortoiliofemoral
35371 Thromboendarterectomy, with or without patch graft; common femoral
35372 Thromboendarterectomy, with or without patch graft; deep (profunda) femoral
Major amputation
27590 Amputation, thigh, through femur, any level
27591 Amputation, thigh, through femur, any level; with immediate ﬁtting technique including ﬁrst cast
27592 Amputation, thigh, through femur, any level; open, circular (guillotine)
27596 Amputation, thigh, through femur, any level; reamputation
27780 Amputation, leg, through tibia and ﬁbula
27781 Amputation, leg, through tibia and ﬁbula; with immediate ﬁtting technique including ﬁrst cast
27782 Amputation, leg, through tibia and ﬁbula; open, circular (guillotine)
27786 Amputation, leg, through tibia and ﬁbula; reamputation
CLI, Critical limb ischemia.
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